186 related articles for article (PubMed ID: 19380819)
1. The avidity and lytic efficiency of the CTL response to HTLV-1.
Kattan T; MacNamara A; Rowan AG; Nose H; Mosley AJ; Tanaka Y; Taylor GP; Asquith B; Bangham CR
J Immunol; 2009 May; 182(9):5723-9. PubMed ID: 19380819
[TBL] [Abstract][Full Text] [Related]
2. Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I.
Goon PK; Igakura T; Hanon E; Mosley AJ; Barfield A; Barnard AL; Kaftantzi L; Tanaka Y; Taylor GP; Weber JN; Bangham CR
J Immunol; 2004 Feb; 172(3):1735-43. PubMed ID: 14734756
[TBL] [Abstract][Full Text] [Related]
3. Degenerate specificity of HTLV-1-specific CD8+ T cells during viral replication in patients with HTLV-1-associated myelopathy (HAM/TSP).
Kubota R; Furukawa Y; Izumo S; Usuku K; Osame M
Blood; 2003 Apr; 101(8):3074-81. PubMed ID: 12480698
[TBL] [Abstract][Full Text] [Related]
4. Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8(+) T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP).
Yamano Y; Nagai M; Brennan M; Mora CA; Soldan SS; Tomaru U; Takenouchi N; Izumo S; Osame M; Jacobson S
Blood; 2002 Jan; 99(1):88-94. PubMed ID: 11756157
[TBL] [Abstract][Full Text] [Related]
5. Increased HTLV type 1 tax specific CD8+ cells in HTLV type 1-asociated myelopathy/tropical spastic paraparesis: correlation with HTLV type 1 proviral load.
Kubota R; Nagai M; Kawanishi T; Osame M; Jacobson S
AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1705-9. PubMed ID: 11080814
[TBL] [Abstract][Full Text] [Related]
6. Lack of recall response to Tax in ATL and HAM/TSP patients but not in asymptomatic carriers of human T-cell leukemia virus type 1.
Manuel SL; Sehgal M; Connolly J; Makedonas G; Khan ZK; Gardner J; Betts MR; Jain P
J Clin Immunol; 2013 Oct; 33(7):1223-39. PubMed ID: 23888327
[TBL] [Abstract][Full Text] [Related]
7. In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Saito M; Matsuzaki T; Satou Y; Yasunaga J; Saito K; Arimura K; Matsuoka M; Ohara Y
Retrovirology; 2009 Feb; 6():19. PubMed ID: 19228429
[TBL] [Abstract][Full Text] [Related]
8. IFN-gamma production in response to Tax 161-233, and frequency of CD4+ Foxp3+ and Lin HLA-DRhigh CD123+ cells, discriminate HAM/TSP patients from asymptomatic HTLV-1-carriers in a Peruvian population.
Best I; López G; Verdonck K; González E; Tipismana M; Gotuzzo E; Vanham G; Clark D
Immunology; 2009 Sep; 128(1 Suppl):e777-86. PubMed ID: 19740339
[TBL] [Abstract][Full Text] [Related]
9. Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load.
Nagai M; Kubota R; Greten TF; Schneck JP; Leist TP; Jacobson S
J Infect Dis; 2001 Jan; 183(2):197-205. PubMed ID: 11120926
[TBL] [Abstract][Full Text] [Related]
10. Functional impairment of Tax-specific but not cytomegalovirus-specific CD8+ T lymphocytes in a minor population of asymptomatic human T-cell leukemia virus type 1-carriers.
Takamori A; Hasegawa A; Utsunomiya A; Maeda Y; Yamano Y; Masuda M; Shimizu Y; Tamai Y; Sasada A; Zeng N; Choi I; Uike N; Okamura J; Watanabe T; Masuda T; Kannagi M
Retrovirology; 2011 Dec; 8():100. PubMed ID: 22151736
[TBL] [Abstract][Full Text] [Related]
11. Human T cell leukemia virus type 1 infection drives spontaneous proliferation of natural killer cells.
Norris PJ; Hirschkorn DF; DeVita DA; Lee TH; Murphy EL
Virulence; 2010; 1(1):19-28. PubMed ID: 20640055
[TBL] [Abstract][Full Text] [Related]
12. An altered peptide ligand antagonizes antigen-specific T cells of patients with human T lymphotropic virus type I-associated neurological disease.
Kubota R; Soldan SS; Martin R; Jacobson S
J Immunol; 2000 May; 164(10):5192-8. PubMed ID: 10799878
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259
[TBL] [Abstract][Full Text] [Related]
14. Anti-Tax antibody levels in asymptomatic carriers, oligosymptomatic carriers, patients with rheumatologic disease or with HAM/TSP do not correlate with HTLV-1 proviral load.
de Souza JG; da Fonseca FG; Martins ML; Martins CP; de Carvalho LD; Coelho-dos-Reis JG; Carneiro-Proietti AB; Martins-Filho OA; Barbosa-Stancioli EF;
J Clin Virol; 2011 Jan; 50(1):13-8. PubMed ID: 20951636
[TBL] [Abstract][Full Text] [Related]
15. Increased HTLV-I proviral load and preferential expansion of HTLV-I Tax-specific CD8+ T cells in cerebrospinal fluid from patients with HAM/TSP.
Nagai M; Yamano Y; Brennan MB; Mora CA; Jacobson S
Ann Neurol; 2001 Dec; 50(6):807-12. PubMed ID: 11761481
[TBL] [Abstract][Full Text] [Related]
16. Advantage of higher-avidity CTL specific for Tax against human T-lymphotropic virus-1 infected cells and tumors.
Kitazono T; Okazaki T; Araya N; Yamano Y; Yamada Y; Nakamura T; Tanaka Y; Inoue M; Ozaki S
Cell Immunol; 2011; 272(1):11-7. PubMed ID: 22030472
[TBL] [Abstract][Full Text] [Related]
17. Fucoidan therapy decreases the proviral load in patients with human T-lymphotropic virus type-1-associated neurological disease.
Araya N; Takahashi K; Sato T; Nakamura T; Sawa C; Hasegawa D; Ando H; Aratani S; Yagishita N; Fujii R; Oka H; Nishioka K; Nakajima T; Mori N; Yamano Y
Antivir Ther; 2011; 16(1):89-98. PubMed ID: 21311112
[TBL] [Abstract][Full Text] [Related]
18. Genetic stability of human T lymphotropic virus type I despite antiviral pressures by CTLs.
Kubota R; Hanada K; Furukawa Y; Arimura K; Osame M; Gojobori T; Izumo S
J Immunol; 2007 May; 178(9):5966-72. PubMed ID: 17442981
[TBL] [Abstract][Full Text] [Related]
19. Multistability in a model for CTL response to HTLV-I infection and its implications to HAM/TSP development and prevention.
Gómez-Acevedo H; Li MY; Jacobson S
Bull Math Biol; 2010 Apr; 72(3):681-96. PubMed ID: 20041353
[TBL] [Abstract][Full Text] [Related]
20. Human T cell leukemia virus type I-induced disease: pathways to cancer and neurodegeneration.
Barmak K; Harhaj E; Grant C; Alefantis T; Wigdahl B
Virology; 2003 Mar; 308(1):1-12. PubMed ID: 12706085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
